Clinical Trial Update: The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

View source ↗

Summary

A clinical trial update shows DISC1 is being explored as a biomarker for cardiovascular disease, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Schizophrenia

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Heart Diseases, Heart; Functional Disturbance | Status: ACTIVE_NOT_RECRUITING